Patents by Inventor Anne K. Holmeide

Anne K. Holmeide has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of polyunsaturated ketones for the treatment of psoriasis
    Patent number: 9375409
    Abstract: Psoriasis is a common, chronic, inflammatory skin disorder. This invention provides the use of a compound of formula (I) R—CO—X (Wherein R is a C16-24 unsaturated hydrocarbon group optionally interrupted ?, ?, ?, or ? to the carbonyl group by a heteroatom or group of heteroatoms selected from S, O, N, SO, SO2 said hydrocarbon group comprising at least 5 non-conjugated double bonds; and X is an electron withdrawing group) in the manufacture of a medicament for the treatment of psoriasis.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: June 28, 2016
    Assignee: Avexxin AS
    Inventors: Berit Johansen, Marit Anthonsen, Wenche Sjursen, Anne K. Holmeide, Lars Skattebol
  • USE OF POLYUNSATURATED KETONES FOR THE TREATMENT OF PSORIASIS
    Publication number: 20150202165
    Abstract: Psoriasis is a common, chronic, inflammatory skin disorder. This invention provides the use of a compound of formula (I) R—CO—X (Wherein R is a C16-24 unsaturated hydrocarbon group optionally interrupted ?, ?, ?, or ? to the carbonyl group by a heteroatom or group of heteroatoms selected from S, O, N, SO, SO2 said hydrocarbon group comprising at least 5 non-conjugated double bonds; and X is an electron withdrawing group) in the manufacture of a medicament for the treatment of psoriasis.
    Type: Application
    Filed: September 16, 2014
    Publication date: July 23, 2015
    Inventors: Berit Johansen, Marit Anthonsen, Wenche Sjursen, Anne K. Holmeide, Lars Skattebol
  • Use of polyunsaturated ketones for the treatment of psoriasis
    Patent number: 8865768
    Abstract: Psoriasis is a common, chronic, inflammatory skin disorder. This invention provides the use of a compound of formula (I) R—CO—X (Wherein R is a C16-24 unsaturated hydrocarbon group optionally interrupted by ?, ?, ?, or ? to the carbonyl group by a heteroatom or group of heteroatoms selected from S, O, N, SO, SO2 said hydrocarbon group comprising at least 5 non-conjugated double bonds; and X is an electron withdrawing group) in the manufacture of a medicament for the treatment of psoriasis.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: October 21, 2014
    Assignee: Avexxin AS
    Inventors: Berit Johansen, Marit Anthonsen, Wenche Sjursen, Anne K. Holmeide, Lars Skattebol